Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
BMJ Open ; 12(9): e057774, 2022 09 19.
Article in English | MEDLINE | ID: mdl-36123107

ABSTRACT

OBJECTIVES: During the COVID-19 pandemic, the UK government and public health leaders advocated for community level responses to support vulnerable people. This activity could be planned and co-ordinated, however much was informal and developed organically. The effects on the individuals who were involved in providing and receiving informal support and implications for their communities have not been widely explored. The aim of this study was therefore to document and explore the nature, potential effects and longevity of community responses to the COVID-19 pandemic. PARTICIPANTS: We asked 15 individuals in North West England to keep a diary during the first UK COVID-19 lockdown. Over 8 weeks, diaries were completed and supported with weekly calls with researchers. A community capacity building framework was used to explore reported community responses to the COVID-19 pandemic. RESULTS: Diarists described community characteristics that enabled and hindered helpful responses in the lockdown context. Diarists frequently described informal approaches with residents acting alone or with near neighbours, although there were examples of community networks and residents recommencing formal volunteering activities. Diarists reported communities providing practical help and social support to vulnerable people. Participants perceived a greater sense of community, increased contact between residents and new networks during the period covered. CONCLUSION: The diaries provided valuable insights and the framework was a useful tool to explore the COVID-19 lockdown context. The findings indicate that organic capacity building took place, primarily via individual agency, highlighting the risk of communities being 'left behind' if there were not individuals or community networks available with resources to plug gaps in organisational support. Recommendations to sustain helpful responses to the pandemic include further consideration of ongoing community mobilisation, empowerment and community control within the capacity building framework.


Subject(s)
COVID-19 , COVID-19/epidemiology , COVID-19/prevention & control , Capacity Building , Communicable Disease Control , Community Networks , Humans , Pandemics
2.
Health Expect ; 25(2): 532-540, 2022 04.
Article in English | MEDLINE | ID: mdl-34939261

ABSTRACT

INTRODUCTION: The social and economic consequences of COVID-19 have the potential to affect individuals and populations through different pathways (e.g., bereavement, loss of social interaction). OBJECTIVE: This study adopted a solicited diary method to understand how mental health was affected during England's first lockdown. We also considered the experiences of diary keeping during a pandemic from the perspective of public participants. METHODS: Fifteen adults older than 18 years of age were recruited from northwest England. Diarists completed semistructured online diaries for 8 weeks, which was combined with weekly calls. A focus group captured participants' experiences of diary keeping. FINDINGS: Four key factors influenced mental health, which fluctuated over time and in relation to diarists' situations. These concerned navigating virus risk, loss of social connections and control and constrictions of the domestic space. Diarists also enacted a range of strategies to cope with the pandemic. This included support from social networks, engagement with natural environments, establishing normality, finding meaning and taking affirmative action. CONCLUSION: Use of diary methods provided insights into the lived experiences of the early months of a global pandemic. As well as contributing evidence on its mental health effects, diarists' accounts illuminated considerable resourcefulness and strategies of coping with positive effects for well-being. While diary keeping can also have therapeutic benefits during adversity, ethical and practical issues need to be considered, which include the emotional nature of diary keeping. PUBLIC CONTRIBUTION: Members of the public were involved in interpretation of data as well as critiquing the overall diary method used in the study.


Subject(s)
COVID-19 , Pandemics , Adaptation, Psychological , Adult , COVID-19/epidemiology , Communicable Disease Control , Humans , Mental Health , SARS-CoV-2
3.
Neuro Oncol ; 15(12): 1635-43, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24158110

ABSTRACT

BACKGROUND: Glioblastoma multiforme with an oligodendroglial component (GBMO) has been recognized in the World Health Organization classification-however, the diagnostic criteria, molecular biology, and clinical outcome of primary GBMO remain unclear. Our aim was to investigate whether primary GBMO is a distinct clinicopathological subgroup of GBM and to determine the relative frequency of prognostic markers such as loss of heterozygosity (LOH) on 1p and/or 19q, O(6)-methylguanine-DNA methyltransferase (MGMT) promoter methylation, and isocitrate dehydrogenase 1 (IDH1) mutation. METHODS: We examined 288 cases of primary GBM and assessed the molecular markers in 57 GBMO and 50 cases of other primary GBM, correlating the data with clinical parameters and outcome. RESULTS: GBMO comprised 21.5% of our GBM specimens and showed significantly longer survival compared with our other GBM (12 mo vs 5.8 mo, P = .006); there was also a strong correlation with younger age at diagnosis (56.4 y vs 60.6 y, P = .005). Singular LOH of 19q (P = .04) conferred a 1.9-fold increased hazard of shorter survival. There was no difference in the frequencies of 1p or 19q deletion, MGMT promoter methylation, or IDH1 mutation (P = .8, P = 1.0, P = 1.0, respectively). CONCLUSIONS: Primary GBMO is a subgroup of GBM associated with longer survival and a younger age group but shows no difference in the frequency of LOH of 1p/19q, MGMT, and IDH1 mutation compared with other primary GBM.


Subject(s)
DNA Methylation , DNA Modification Methylases/genetics , DNA Repair Enzymes/genetics , Glioblastoma/genetics , Isocitrate Dehydrogenase/genetics , Loss of Heterozygosity , Mutation/genetics , Oligodendroglioma/genetics , Tumor Suppressor Proteins/genetics , Adult , Aged , Aged, 80 and over , Brain Neoplasms/diagnosis , Brain Neoplasms/genetics , Brain Neoplasms/mortality , Chromosomes, Human, Pair 1/genetics , Chromosomes, Human, Pair 19/genetics , Female , Follow-Up Studies , Glioblastoma/diagnosis , Glioblastoma/mortality , Humans , Male , Middle Aged , Neoplasm Staging , Oligodendroglioma/diagnosis , Oligodendroglioma/mortality , Prognosis , Promoter Regions, Genetic/genetics , Survival Rate
4.
Acta Neurochir (Wien) ; 152(6): 1075-7, 2010 Jun.
Article in English | MEDLINE | ID: mdl-19936608

ABSTRACT

Low-grade primary T-cell lymphoma of the central nervous system is extremely rare. We present a case developing in a previously fit young woman presenting with symptoms of raised intracranial pressure and found on CT to have a cerebellar mass. Biopsy of this lesion revealed features of non-Hodgkin's lymphoma with histochemical analysis confirming T-cell phenotype and a Ki67 proliferation index of only 1%. Contrary to the prevailing view in the literature, the patient's clinical condition deteriorated following high-dose intravenous methotrexate and improved after a short course of whole-brain radiotherapy.


Subject(s)
Antimetabolites, Antineoplastic/therapeutic use , Cerebellar Neoplasms/drug therapy , Cerebellar Neoplasms/radiotherapy , Cranial Irradiation , Lymphoma, T-Cell/drug therapy , Lymphoma, T-Cell/radiotherapy , Methotrexate/therapeutic use , Adult , Antimetabolites, Antineoplastic/adverse effects , Antineoplastic Agents, Hormonal/therapeutic use , Biomarkers, Tumor/analysis , Biopsy , Cerebellar Neoplasms/diagnosis , Cerebellar Neoplasms/pathology , Cerebellum/pathology , Combined Modality Therapy , Dexamethasone/therapeutic use , Dose-Response Relationship, Drug , Female , Humans , Infusions, Intravenous , Ki-67 Antigen/analysis , Lymphoma, T-Cell/diagnosis , Lymphoma, T-Cell/pathology , Magnetic Resonance Imaging , Methotrexate/adverse effects , Neurologic Examination , Radiotherapy, Adjuvant , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL
...